Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
CBSN
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option.
The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose - a fifth of the dose of its current COVID-19 vaccine, Spikevax - by refining its immune target.
The approval "adds an important new tool to help protect people at high risk of severe disease from COVID-19," Stephane Bancel, Moderna's CEO, said in a statement Saturday.

The Federal Communication Commission announced Thursday evening that it had approved the $6.2 billion merger of major broadcast station owners Nexstar and Tegna. The move came on the same day that attorneys general in eight states and DirecTV filed separate lawsuits seeking to block the deal, arguing that it will lead to higher prices for consumers and stifle local journalism. In:












